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Questions  
1. What is the pathognomonic sign of JS?  
2. What are the clinical features of JS?  
3. What are the renal manifestations typically seen in JS  
including the radiological and histological findings?  
4. What features of this boy’s biopsy was unusual for JS?  
Answers  
Question 1  
Joubert syndrome (JS) was first described by Dr Marie Joubert in 1968 in a family of four siblings, all of whom 
presented with cerebellar vermis agenesis, ataxia, oculomotor abnormal- ities and developmental delay. 
Subsequently, a neuroradiolog- ical mid-hindbrain malformation, known as the ‘molar tooth sign’ (MTS), was 
identified. This malformation is caused by hypoplasia of the cerebellar vermis with fourth ventricle de- formity 
and a sagittal vermian cleft due to incomplete vermis fusion. Elongated and thickened superior cerebellar 
peduncles with a widened interpeduncular fossa are also present [1]. The absence of a normal vermis results in a 
midline cleft between the cerebellar hemispheres, resulting in the ‘bat wing’ sign on an magnetic resonance 
imaging (MRI) scan [2]. The term Joubert syndrome and related disorders (JSRD) was then established to 
describe a group of other conditions commonly sharing the MTS. The JSRD spectrum includes JS with retinal 
disease, JS with hepatic disease, JS with orofaciodigital dis- ease and JS with renal disease. The MTS is widely 
thought to be pathognomic of JSRD, although there is some disagree- ment in the literature [3, 4].  
Question 2  
The typical features of JS are hypotonia evolving into ataxia and developmental delay, usually associated with 
impaired intellectual function, and abnormal ocular movements [5]. Respiratory pattern abnormalities may 
occur in the first few months of life which typically manifest as apnoeic episodes or episodic hyperpnoea [6]. 
Oculomotor dyspraxia is one of the most characteristic neurological abnormalities and presents as an inability to 
fix and follow accompanied by compensatory head movements and, commonly, as positional nystagmus. Most 
children with JS have a degree of intellectual impair- ment although the severity of this can be very variable [7].  
In addition to the typical neurological features, there are also renal, ocular, hepatic and skeletal abnormalities. 
The oc- ular issues result from retinal dystrophy and present with re- duced visual acuity which can progress to 
retinal blindness [8]. Colobomas can also be present, normally affecting the posterior segment of the eye [9].  
A small number of patients with JS develop liver disease, usually in the form of congenital hepatic fibrosis, due 
to prob- lems in embryogenesis and resultant portal tract fibrosis [10]. An association between JS and 
polydactyly has been repeat- edly observed, with a frequency of 8–16% [11], as well as mild to severe scoliosis 
(probably secondary to hypotonia) [12].  
Question 3  
The reported prevalence of renal disease in JSRD is approxi- mately 23–30% [13, 14], and the condition 
presents as nephronophthisis (NPHP). Previously, patients with cystic dysplastic kidneys and the MTS had been 
designated as hav- ing a separate syndrome, known as Dekaban–Arima syn- drome, but in fact on re-evaluation 
many of these had histo- logical findings in keeping with NPHP and, consequently, the existence of this 
syndrome is questionable [15].  
NPHP patients typically present with polyuria and polydip- sia, and NPHP ultimately leads to progressive renal 
failure, usually within the first three decades of life [16]. The predom- inant form of NPHP is juvenile, although 
a much rarer infan- tile form also exists. The typical features revealed by ultraso- nography are normal or 
reduced kidney size [note that normal- sized kidneys in end-stage renal disease (ESRD) is unusual], loss of 
corticomedullary differentiation and small cysts at the corticomedullary junction [17]. On renal biopsy, 
structural tubulointerstitial abnormalities are seen including tubular at- rophy, interstitial fibrosis and tubular 
basement membrane defects [18]. (Note that in infantile NPHP there can be en- larged kidneys on the ultrasound 
scan, and renal biopsy find- ings include cortical microcysts and normal tubular basement membrane.)  
Question 4  
In general, juvenile NPHP presents with biopsy findings of severe chronic tubulo-interstitial changes with 
secondary tu- bular dilatation but with minimal inflammation. Conversely, tubulointerstitial nephritis (TIN) 
usually shows marked inter- stitial inflammation with minimal chronic change. In this boy’s biopsy there was 
extensive lymphocytic infiltration of tubules and a dense interstitial inflammatory infiltrate of lym- phocytes, 
presenting a histological picture of acute TIN rather than the expected picture of chronic change one would 
expect in NPHP.  
Discussion  
In this report we describe a missed diagnosis of JS in a 9-year- old boy. JS is rare, with an estimated incidence 
of between 1 in 80,000 to 1 in 100,000 live births globally [19], although the  
incidence is higher in areas of the world with higher rates of consanguinity [14]. It is important to consider it in 
any child presenting with hypotonia, pathological ocular movements (both nystagmus or oculomotor apraxia) 
and developmental delay. The diagnosis can be confirmed with a brain MRI to determine the presence of the 
MTS.  
Once a diagnosis of JS is made, careful assessment of other organ involvement is the next step. Renal 
assessment must include renal function, urinalysis (looking specifically for con- centrating defects) and 
ultrasonography examination. It is cur- rently recommended that such screening tests occur annually [19]. If 
there is any suspicion of NPHP, renal biopsy or genetic testing can be performed for confirmation.  
The ultrasound findings of normal sized kidneys and loss of corticomedullary differentiation in this case are 
fairly non- specific although they fit with underlying NPHP. The difficul- ty in this case was the unusual biopsy 
findings. Although subsequent retrospective review of the biopsy confirmed the diagnosis of JS, the histological 
findings point to an acute TIN. As such, this case is an atypical histological presentation of NPHP.  
The NPHP of this patient was confirmed by genetic testing. JS is an autosomal recessive condition, and a 
number of mu- tations in genes encoding proteins of the primary cilium have been identified, hence the 
classification of JS and JSRD as ‘ciliopathies’ and the clinical manifestations of the disease. Note that there 
have been rare cases of X-linked recessive inheritance (OFD1 mutation as an interacting partner of the LCA5-
encoded ciliary protein lebercilin) [20]. To date, at least 25 genes have been identified, although the number is 
rapidly expanding [21].  
Approximately 25% of all NPHP cases involve a de- letion in the NPHP1 (nephronophthisis 1) gene [16]. 
Conversely, only 10% of children with NPHP have extrarenal abnormalities (including the MTS and JS), and 
the prevalence of NPHP1 deletions in JS is rare, although reported variably in the literature [22]. It is 
recommended that all children presenting with features of NPHP should be screened for this deletion. If a mo- 
lecular genetic diagnosis can be made, then a renal bi- opsy should not be necessary. The boy in the case re- 
ported here was homozygous for the common 290-kb deletion in NPHP1 (PCR analysis revealed a homozy- 
gous deletion of both exon 5 of the NPHP1 gene and DNA marker 187.41, but not for the control site on 
chromosome 2 q35, and therefore no further testing was undertaken). His parents have not been tested for 
carrier status due to resource availability. Of note, he has two unaffected half siblings.  
NPHP1 encodes a protein called nephrocystin-1 that has been identified in the primary renal cilia as well as the 
cell adherens junctions [23]. Patients with deletions in NPHP1 appear to move towards end stage kidney disease 
(ESKD)earlier than those with mutations in other genes involved in JS, such as NPHP1-6, NEK8, RPGRIP1L 
and AHI1, amongst others.  
In conclusion, this report highlights the importance of keeping a wide differential diagnosis in mind when a 
patient presents with a complex phenotype involving multiple organ systems. Retrospective reviews of imaging 
studies previously reported to be normal can on occasion be useful in identifying signs of disease.  
 
